Introduction
Respiratory diseases can cause great distress to individual animals. They also have a serious effect on performance and production in affected groups of pigs. They are a major problem to the pig industry, and the potential cost of outbreaks of respiratory disease is high. A number of pigs may die, and there may be a reduction in food conversion efficiency and a decrease in meat quality in those that survive. Pigs that survive but are left with pathological lesions may also have a greater risk of condemnation at slaughter.
Aetiology of respiratory disease
Various causes of respiratory disease have been identifi ed, including viruses, mycoplasmas, bacteria, and parasites. Secondary bacterial infection of lung tissue already compromised by primary pathogens frequently occurs. Poor biosecurity predisposes to the introduction and spread of respiratory diseases. In many cases, the causal agents are highly infectious. They may spread by direct or aerosol contact between pigs and be transmitted by birds and vehicles in addition to airborne spread between units.
Epidemiology of respiratory disease
A large number of diseases can affect the respiratory system. More than one respiratory disease can affect a unit at the same time. The porcine respiratory system has physical and immunological defence mechanisms against disease. These defences can be overcome by overwhelming levels of infection, poor immunity, poor management, adverse environmental factors, and the presence of other diseases. Poor ventilation and insulation, poor diet, an inadequate water supply, overcrowding, and high levels of dust and ammonia are particularly important environmental risk factors. Experimental work has shown that exposure to high levels of dust and ammonia do not necessarily result in an increase in respiratory disease. A failure to recognize and treat respiratory disease at an early stage predisposes to severe outbreaks of respiratory disease. These exacerbate the negative effects of respiratory diseases on growth and production. Failure to segregate the various age groups on the unit may also predispose to outbreaks of disease, including those affecting the respiratory system. This is especially likely to occur where there is common airspace or airfl ow for all ages of pig.
Clinical signs of respiratory disease
One of the fi rst signs of respiratory disease is coughing, which may be particularly noticeable when pigs get up from rest. Coughing is especially severe in cases of enzootic pneumonia when large numbers of pigs in a group are affected. Dyspnoea accompanies a number of respiratory diseases. If breathing is slow and accompanied by snuffl ing sounds it may indicate the presence of nasal obstruction, which often accompanies rhinitis.
Dyspnoea with hyperpnoea may indicate severe compromise of lung function. In cases of severe respiratory distress, affected pigs may breathe through their open mouth and may have a 'respiratory line' caused by tightening of the abdominal muscles as they attempt to force air from inelastic lung tissue ( Fig. 4.1) .
Heart failure and cor pulmonale may develop in animals suffering from severe or chronic respiratory disease. Pleurisy with adhesions between lung tissue and the chest wall may further compromise respiratory function and effi ciency.
Only a limited physical clinical examination may be possible in pigs suffering from respiratory disease. Brief auscultation of the chest may be possible, and increased lung sounds and specifi c sounds of pneumonia and pleurisy may be audible. Wheezing sounds may indicate narrowing of the airways; bubbling sounds may indicate intermittent blocking of bronchioles. High-pitched squeaking sounds may indicate the presence of pleuritis, and harsh rubbing sounds may occur in cases of pleurisy. In some cases, it may be possible to identify which parts of the lungs are affected and whether there are signs of cardiac disease or pleurisy. Any attempt to restrain the pig may increase the severity of the clinical signs, and it may be life-threatening in severe cases.
Animals with respiratory disease are often anorexic and soon have an empty appearance. An ocular discharge may be present, and a nasal discharge may be seen in cases of rhinitis. Death of untreated pigs and sudden deaths may occur with a number of respiratory diseases. Post-mortem examination can be extremely helpful in confi rming the diagnosis of the cause of the respiratory disease. The distribution and nature of gross lesions can be observed and samples taken for diagnostic purposes.
Some respiratory diseases, such as enzootic pneumonia and porcine reproductive and respiratory syndrome (PRRS), readily become endemic in affected herds. When fi rst introduced, they may be quite acute but later become chronic. Such diseases have an adverse effect on welfare and production. Other diseases, such as swine infl uenza and some outbreaks of pleuropneumonia, are more acute and may have a shorter course on affected units.
Porcine respiratory diseases remain a challenge to the pig industry. Outbreaks of such diseases should be investigated quickly and thoroughly. Treatment and preventive measures must be put in place to ensure that the adverse effects of diseases are kept to a minimum.
Diagnosis of respiratory disease
Accurate diagnosis of the cause is essential in outbreaks of respiratory disease. The history of the unit, clinical examination, and observation may provide a tentative diagnosis. This must be confi rmed by specifi c laboratory tests and a full post-mortem examination of dead or very sick pigs. Information from abattoir surveillance of slaughtered pigs may indicate the nature and level of any existing respiratory disease. More than one respiratory infection may be present on a unit at the same time. It is essential if all potential causes are identifi ed to ensure that effective and specifi c control methods can be instituted.
Treatment of respiratory disease
Once the diagnosis has been determined, treatment can commence and plans for future prophylaxis discussed with the owner. In recent years, effective vaccines have been developed for many of the major porcine infectious respiratory diseases. New antibiotics have been developed that have improved penetration into lung tissue, permitting more effective treatment of primary and secondary infections. Whenever antibiotics are used, care must be taken to ensure that meat withdrawal times are observed.
Antibiotic therapy is usually prescribed and can be administered in the water or food to affected and at-risk animals. Sick pigs are usually treated parenterally, as they will often be too ill to either eat or drink. Severely ill animals may be euthanized on humane or economic grounds.
Control of respiratory disease
Ideally, infectious respiratory diseases should be eliminated from the unit or their incidence and severity reduced to controllable levels. Once eliminated or controlled, future levels of disease should be monitored. This can be done by careful observation, clinical examination of sick pigs, and post-mortem examination of any pigs that die. The respiratory systems of slaughter pigs should be examined and monitored at the abattoir. All infections present should be identifi ed.
Elimination of respiratory disease may be attempted by a number of methods. Some of these are discussed below in relation to specifi c diseases. All require determination and dedication, especially by farm owners and staff. Potential elimination methods include the establishment of a specifi c pathogen-free (SPF) herd from hysterectomyderived stock. Alternatively, early weaning and segregation or strategic medication can be used. Once high health status is achieved, it must be maintained by high herd biosecurity. Vaccines are available for some but not all respiratory infections.
Comparative notes on some infectious diseases of the porcine respiratory system are presented in Table 4 .1.
Veterinary Investigation Diagnosis Analysis sample submissions: respiratory diseases, 1996-2003
See 
Enzootic pneumonia
This is a very important disease of pigs that causes severe economic loss through clinical disease and an adverse effect on food conversion and weight gain.
Incidence
This disease has widespread occurrence throughout the world. It is probably the most important and most common porcine respiratory disease in intensive pig units, and has low mortality but high morbidity.
Aetiology
The cause is Mycoplasma hyopneumoniae with frequent superimposed secondary infection, especially by Pasteurella multocida (type A). The disease can also be worsened by the simultaneous presence of atrophic rhinitis and ascariasis. Mycoplasma hyopneumoniae alone can cause lung damage, but this will usually resolve spontaneously. Environmental problems and secondary infection are responsible for the more chronic signs and poor performance. Infection can be induced by the administration of aerosol cultures of Mycoplasma hyopneumoniae.
Epidemiology
The organism lives in the pig's respiratory system, where it can compromise epithelial function. On entering the body, it becomes attached to the ciliated cells of the trachea, bronchi, and bronchioles. The organism survives for a short time only in the environment out of the body. Spread is mostly by pig to pig contact, by aerosol transmission, and also by wind. Poor housing, variable temperatures, high humidity, mixing of pigs from different sources and ages, overcrowding, and continuous throughput systems all predispose to a greater severity of disease. The numerous contributory aetiological factors make assessment of each factor diffi cult. Immunity can be short-lived, and there is no transfer of colostral immunity from sow to litter. Infection can pass from the sow to her piglets in the fi rst few days of life.
Infection of a naive herd may lead to signs of pneumonia in all ages, from 10-day-old piglets to sows. In chronically infected herds, the growing (post-weaning) pig is most often clinically affected. Up to 90% of pigs in the latter herds may show lung pathology at slaughter. Daily weight gain may fall by up to 17% and feed effi ciency by 14%. Between 23 and 37 g in weight gain is lost per day for every 10% of lung affected by pneumonia. The appearance of lungs at slaughter, although useful, is not necessarily a good indication of the true extent of a herd infection.
Clinical signs
Prolonged non-productive coughing, worsened by exercise, is the main sign of the disease in affected herds. Individual animals, especially those with secondary infection by P. multocida, may show signs of severe respiratory distress. Such animals are sometimes called panters, with temperature 40-42°C and possibly open-mouthed breathing. A more productive cough may be heard in such animals. Increased lung sounds may be heard if the 
Differential diagnosis
Differential diagnoses include other porcine respiratory diseases, especially the following.
• Actinobacillus pleuropneumoniae. This tends to be more acute and has a high mortality rate, and the lungs have a characteristic gross pathological appearance at post-mortem. It affects the dorsocaudal parts of the lung lobes rather than the cranioventral areas. • Metastrongylus apri infestation in outdoor pigs;
parasites are found in the bronchi. • Swine infl uenza. This has a short course and is less common, and the pathological changes are chiefl y in the upper respiratory tract. • Glasser's disease. There is sudden onset of polyserositis, with joints affected. Culture Haemophilus parasuis.
Treatment
Acute cases may respond to antibiotic therapy (e.g. tylosin, tiamulin, and enrofl oxacin). Florfenicol and tulathromycin have recently (2003) (2004) been licensed for use in pigs. Early treatment is essential, and a full course of treatment must be given. Tilmicosin is given in food for 15 days. Valnemulin premix is an option. Lincomycin is also effective. Steroids or non-steroidal anti-infl ammatory drugs (NSAIDs) may aid resolution of acute individual cases. Strategic dosing of growing pigs may be necessary on some farms if signs of respiratory disease appear.
Control
Various strategies are available depending on the severity of disease and economic considerations. These include the following. • Improve environment and management. Make sure all aspects of husbandry, such as ventilation and the separation of different age groups, are as good as possible. • All in, all out management of growers. After each batch, the building is pressure washed, fumigated, and rested for as long as possible before the next batch of pigs is admitted. • Depopulate infected herd and -after thorough cleaning, fumigation, and resting -repopulate with 'disease-free pigs', but great care must be taken to ensure that they are really enzootic pneumoniafree. • Repopulate with hysterectomy-derived pigs. Piglets obtained in this way are reared artifi cially away from their mothers. Such closed SPF herds are costly to produce and diffi cult to maintain. • Partial depopulation and treatment. In this system, an attempt is made to keep the original breeding stock but remove (to other premises) all other pigs in the unit. The breeding stock pigs are treated with tiamulin in their water or food for 10 days. Future offspring should be relatively free of enzootic pneumonia. • Medicated early weaning. In this system, farrowing sows are fed on a ration containing tiamulin until their piglets are 5 days old. The piglets are then removed and reared in isolation. They are kept on oral tiamulin in their food until they are 10 days old. They are then grown on away from other pigs on the farm. • Vaccination (see below).
Monitoring the incidence of enzootic pneumonia
This includes examination of batches of lungs at slaughter and serum profi ling of the herd using an ELISA test.
Vaccination
Inactivated, adjuvanted vaccines against Mycoplasma hyopneumoniae have helped control enzootic pneumonia very effectively in some herds. In some cases, a single dose of vaccine given at about 1 week of age is used, and in some cases a second dose is used 3 weeks later. Data sheets should be consulted before use. Trials of the vaccines have shown reduced mortality, better food conversion, and reduced costs. An inactivated vaccine is also available for the control of both enzootic pneumonia and Glasser's disease. Trials have been held to compare the effi cacy of vaccination against enzootic pneumonia with herd medication. Both have been shown to help, but there appears to be little benefi t in using both methods at the same time.
Progressive atrophic rhinitis
This is an important disease of pigs that adversely affects their welfare, food conversion, and growth rate. Progressive and non-progressive forms of the disease have been described depending on whether nasal turbinate damage is present.
Incidence
The disease has worldwide distribution, adversely affecting production and the welfare of affected pigs in intensive units. Growth rate can be reduced, and the predisposition to pneumonia is increased. Up to 50% of pigs in an infected herd may show evidence of snout deformity in abattoir surveys. Poor housing, overcrowding, and insuffi cient ventilation can increase the incidence of the disease.
Aetiology
Toxigenic strains of Bordetella bronchiseptica and P. multocida type D cause this disease. In the progressive form, toxigenic P. multocida is present.
Epidemiology
The infection can spread by direct or droplet contact between pigs. The main route of spread is between an infected sow and her litter in their fi rst week of life. The effects of infection are worse in pigs affected at this early age than in older piglets. Further spread occurs when batches of piglets are mixed, for example in fl at deck systems after weaning.
Bordetella bronchiseptica is a common inhabitant of the pig's nasal cavity. Infection with this bacterium results in mild, reversible, and temporary turbinate damage and eventual elimination of infection. Occasionally, rhinitis, tear staining, and pneumonia are seen in suckling piglets. The organism produces a cytotoxin that assists P. multocida gain access to the turbinate bones. This latter organism produces an osteolytic toxin that has a predilection for the turbinate bones. The turbinates are progressively destroyed with secondary involvement of the nasal mucosa. Growth rate may fall by up to 13%; this is thought to be due to the nasal irritation and obstruction that interferes with suckling and prehending food.
Clinical signs
In most cases, these are fi rst seen at 3-9 weeks of age. Piglets sneeze and have a clear or purulent nasal discharge. They may rub their blocked noses on the fl oor. Once infection by P. multocida is established, nasal haemorrhage may be seen. Later, evidence of facial deformity ( 7) is seen. If both nasal cavities are affected, the snout may be 'dished' and concave. In unilateral infection, lateral deviation of the snout is seen. Malocclusion of teeth may occur, and the pig has diffi culty in prehending its food. There may be reduced pheromone recognition in breeding animals. 
Diagnosis
Causal organisms can be cultured from the nose. Serological tests are available for B. bronchiseptica but not for P. multocida.
Post-mortem -This reveals a degree of destruction of the turbinates. The snout is sectioned at the level of the second premolar, and damage is estimated on a scale of 0 (no turbinate damage) to 5 (almost total loss of turbinates). The nasal septum may be twisted or displaced. 
Differential diagnosis
Differential diagnoses are other forms of rhinitis. • Bordetella bronchiseptica infection by itself causes catarrhal rhinitis, tear staining, and occasionally pneumonia in pigs >1 week but usually no signs of snout deviation in older pigs. Culture of the organism and a serological ELISA test are used to confi rm the diagnosis (Fig. 4.8 
Control
Ideally, depopulate and restock with atrophic rhinitis-free pigs. Strategic medication may be used, especially for pigs showing signs of rhinitis. Improving housing and reducing stocking rates may help. Screening herds can be done with an ELISA test for B. bronchiseptica. Tonsillar swabs or swabs from the posterior nares can be cultured. At least 18 negative swabs are required to say that a herd is free.
Vaccination
Vaccination of sows and gilts may help prevent the establishment of disease in their piglets. Primary vaccination is by two intramuscular doses 6 weeks apart. Then vaccinate sows twice yearly 2-6 weeks before each farrowing is due. The vaccine contains P. multocida dermonecrotic toxoid and inactivated B. bronchiseptica. Great care is required when using the vaccine, which can cause severe reaction in people if accidentally injected.
Pleuropneumonia of pigs
This is an important respiratory disease that can be associated with severe economic loss. It is highly contagious and can be fatal.
Incidence
There is widespread evidence of infection in North America, Asia, and Europe.
The infection is found frequently when there is no evidence of clinical disease. It is responsible for 17.03% of cases in the Veterinary Investigation Diagnosis Analysis list for 1996-2003.
Aetiology
The cause is Actinobacillus pleuropneumoniae. There are 12 serotypes of variable virulence. The organism produces a number of pathogenic toxins that lower defences by killing macrophages and neutrophils.
Epidemiology
The disease has relatively low clinical incidence but high mortality. It is usually brought into a herd by a carrier (often recovered) pig. The carrier pig may have infected foci in necrotic areas of the lungs. The severity of the diseases may be exacerbated by the presence of other diseases, such as PRRS or swine infl uenza. Sudden outbreaks of the disease are occasionally seen when no other pigs have been introduced into the herd. Infection is exacerbated by poor housing and ventilation. It chiefl y affects pigs from 2 to 6 months of age and is seen occasionally in fi nishing pigs approaching slaughter weight. High condemnation rates may be seen at slaughter. Piglets aged <10 days may have colostral protection. Weight gain losses of up to 20% have been reported in some herds.
Clinical signs
The clinical signs have a sudden onset. Typically, one or two sudden deaths occur and other pigs are severely ill, anorexic, and depressed with pneumonia. In acute cases, temperature may be 41°C but may fall as a pig becomes terminally ill. There is dyspnoea with jerky breathing and coughing. Blood-stained foamy mucus may be seen coming from the nose and mouth. Pigs may die within a few hours of showing clinical signs. Some pigs are cyanotic as a result of cardiac failure. Abortion may occur in sows. Other pigs in the group may be less severely affected, showing subacute or chronic signs. Coughing, weight loss, and a poor appetite are seen. Meningitis occurs occasionally.
Diagnosis
Diagnosis is by serological ELISA test and culture of the causal organism from nasal swabs or lung tissue.
Post-mortem -There is acute, fi brinous, haemorrhagic pleuropneumonia. In peracute cases, the lung is dark red and fi rm to the touch, with blood running from the cut surfaces. Lesions are black-red raised areas, especially in dorsal parts of both lungs including the diaphragmatic lobes (Figs 4.9 and 16.13). Many cases also have fi brinous pleurisy and pericarditis. In chronic cases, a high incidence of pleurisy may be seen at the abattoir. Pathology can occasionally be confi ned to one lung.
• Necrotic rhinitis is uncommon but may accompany atrophic rhinitis. It is caused by Fusobacterium necrophorum, with resulting rhinitis and facial swellings. Necrotic lesions are also found in the mouth and on the skin. The disease carries a high mortality. • Inherited prognathia. Individual piglets have excessively long lower jaws.
Treatment
Antibiotic therapy may help reduce the severity of clinical signs shortly after infection, but there is no cure for facial deformity. Tylosin and trimethoprim-sulpha given parenterally at intervals may reduce problems in growing piglets. Tilmicosin can be fed in creep feed continuously for 6 weeks, but it may be diffi cult to get piglets to eat enough to obtain a therapeutic dose. 
Glasser's disease
This is an acute infection causing polyserositis, arthritis, and meningitis. Respiratory signs are seen chiefl y in older pigs.
Incidence
It occurs worldwide.
Aetiology
The cause is Haemophilus parasuis, which has many serotypes.
Epidemiology
The causal organism(s) is found in the nasal cavity of many pigs. The onset of disease may be associated with exposure to stress such as transport or movement to new pens. The disease may follow other infections such as swine infl uenza. Although thought to be chiefl y a secondary invader, the organism may be a serious primary pathogen in SPF herds. Piglets may have colostral immunity, and Glasser's disease is seen chiefl y in pigs from weaning to 4 months of age. The disease can be a complication of other respiratory diseases such as enzootic pneumonia and PRRS.
Clinical signs
These usually have sudden onset, and several pigs are affected at the same time. Affected animals show pyrexia (temperature, 41°C), anorexia, cough, and dyspnoea. Lameness is also seen, with swollen joints and pigs walking with short strides and on tiptoes. Central nervous system
Differential diagnosis
• Enzootic pneumonia. This is usually a more chronic infection with greater ventral consolidation of the lungs at post-mortem. 
Treatment
Parenteral antibiotic treatment is given for severely affected pigs; spectinomycin, tilmicosin, oxytetracycline, and ceftiofur can all be used. Sensitivity tests may help decide which antibiotic to use. Early treatment is essential before intractable pathology is established. Mass medication by injection is used for severely affected pigs, or in water or feed for in-contacts if infection is spreading. Isolate clinically affected animals; this may help reduce spread within a group. NSAIDs may aid recovery in acute cases.
Control
Ideally, keep infection out by having a closed herd and purchasing any replacements only from repeatedly serologically negative herds. Try to either eradicate or control the disease.
Eradication -This involves depopulation, thorough cleaning, and repopulation with serologically negative (perhaps hysterectomy-derived) pigs. Piglets may be weaned at 10 days (they are immune to disease until then), medicated (as above), and moved to a separate unit. Rear pigs in isolation and move to a separate fi nishing unit.
Vaccination -The large number of serotypes of A. pleuropneumoniae make effective vaccination diffi cult, although autogenous vaccines have been used. A commercial vaccine is not currently available in the UK. signs may develop in untreated cases, and discoloration of the skin may precede death. Chronic cases may follow initial infection: chronic arthritis, intestinal obstruction caused by peritonitis, and heart failure. Deaths and abortion have been reported in sows suddenly exposed to Glasser's disease in SPF herds.
Porcine pasteurellosis
Strains of the organism Pasteurella multocida are important as secondary invaders in a number of porcine respiratory diseases including enzootic pneumonia, atrophic rhinitis, and pleuropneumonia. The organism can also act as a primary pathogen, producing either pneumonic pasteurellosis or Pasteurella septicaemia.
Pneumonic pasteurellosis
Incidence This is a common respiratory disease of pigs. Cases of acute pasteurella pneumonia are seen, sometimes secondary to other infections. Pneumonic pasterellosis has worldwide distribution.
Aetiology
Pasteurella multocida is the cause; a number of different strains are recognized.
Epidemiology
Cases are mostly sporadic in 10-to 20-week-old growing pigs, but several pigs may be affected. The causal organism is found in many pigs, and stress may predispose to acute infection. The organism may also require prior lung damage by another pathogen, such as Mycoplasma hyopneumoniae or A. pleuropneumoniae, to become established and cause pneumonia.
Diagnosis
Diagnosis is based on history and clinical signs, PCR, ELISA, complement fi xation tests on serum, and culture of the organism from joints and other tissues (e.g. the pericardium). Culture is diffi cult and requires special media.
Post-mortem -Polyserositis, polyarthritis, and fi brinous meningitis are found (Fig. 4.10) .
Differential diagnosis
• Swine erysipelas. Mostly chronic lameness is present, with epiphyseal enlargement rather than swelling of joint capsules. Culture the organism. • Mycoplasma hyosynoviae. This is a milder disease.
Culture serology is used. • Streptococcal infections. These often lead to meningitis. Culture to confi rm diagnosis.
Treatment
Injections of penicillin-streptomycin, oxytetracycline, or trimethoprim-sulpha are given to sick pigs. Incontacts are given oral medication in water or food (if eating). Sensitivity tests are advisable if large numbers of pigs are affected or if there is a poor response to treatment. Early treatment is essential to avoid the establishment of pathological problems that might prevent an effective cure.
Control
Avoid stress. Strategic medication may be used at times of high risk, for example after moving if there has been a recent history of disease.
Vaccination -An inactivated vaccine is available for the prevention of Glasser's disease and enzootic pneumonia. The fi rst injection (2 mL i.m.) is given at >1 week of age, the second dose 2-3 weeks later. The complete course is given by <10 weeks of age. Experimental vaccination of both gilts and their piglets may produce better results. 
Septicaemic pasteurellosis
This is a cause of sudden death in young and growing pigs.
A sudden onset of depression may precede some deaths. Post-mortem reveals a septicaemic carcass with congested lymph nodes. The skin of the abdomen and ears may be cyanotic. The organism is found in impression smears of lymph nodes and the sectioned spleen. Differential diagnoses are other causes of sudden death including clostridial infection.
Swine infl uenza
Swine infl uenza is an acute respiratory infection with rapid onset, spread, and resolution.
Incidence
The disease occurs in North America, the Far East, and Europe. The fi rst UK case was seen in 1986.
Aetiology
The cause is infl uenza A virus, an orthomyxovirus with a number of subtypes. The H1 N1 strain has been seen in the UK and elsewhere. Other human infl uenza strains have also been found in pigs not showing signs. Aquatic and other birds may also carry the swine infl uenza virus.
Epidemiology
Direct pig to pig transmission via infected droplets is the most important method of spread, but airborne infection can also occur. There may be a sudden onset of disease, often after a few days' bad weather. Young pigs are most frequently affected, but infection can spread throughout a whole herd. Severity may be worsened by the presence of other respiratory pathogens and also by migrating ascarid larvae. Other respiratory pathogens may gain access to the respiratory system that has been weakened by swine infl uenza infection. There is no evidence of carrier pigs, and the organism often disappears from the herd after an outbreak of acute infection.
Clinical signs
Clinical signs are incubation over 2-7 days, rapid spread through pigs, temperature of 41.5°C, anorexia, jerky breathing, sneezing, painful (sometimes paroxysmal) cough, and sometimes prostration. The ocular conjunctivae are infl amed, and some ocular discharge is present. Muscular movement is painful and stiff (as in human fl u). Severe weight loss occurs despite the short course of the disease. Usually, rapid recovery occurs in 4-6 days. The disease has high morbidity but low mortality. Convulsions may occur before death. Sows may abort
Treatment
Treatment is by antibiotic therapy: penicillinstreptomycin or oxytetracycline, trimethoprim-sulpha, and ampicillin. A sensitivity test is advisable if several cases are seen or if there is a poor initial response to treatment.
Diagnosis
Diagnosis is by clinical signs and isolation of the organism.
Post-mortem -Acute necrotizing and fi brinous pneumonia are seen. Grey-pink consolidation is present, especially in anterior lung lobes. There is an absence of other active infectious causes of pneumonia ( Fig.  4.11) .
Control
Improve management and try to reduce predisposing stress. Segregated early weaning can be very effective in controlling the disease. 
SWINE INFLUENZA

Clinical signs
These are pyrexia, anorexia, and dyspnoea; one may see open-mouthed breathing, coughing, and some sudden deaths. Some treated cases may become chronic, with reduced growth rate and tendency to relapse.
Differential diagnosis
Differential diagnoses are other causes of pneumonia.
following infection, and surviving piglets may be born with deformed or infected lungs. Increased numbers of pigs with middle ear disease may be seen. These may result from bacterial infection following viral damage.
Swine infl uenza infection is occasionally asymptomatic but may facilitate the access of other diseases such as Glasser's disease.
Control
Maintain a closed herd. Vaccination with an oiladjuvanted vaccine has been used in some countries. Protecting pigs from adverse weather may help reduce the severity of the disease.
Treatment
Oral or parenteral antibiotics may help control secondary infection with H. parasuis and A. pleuropneumoniae. Oxytetracycline in water or food may help. Nursing care with warmth and good ventilation may help recovery.
Differential diagnosis
• Enzootic pneumonia is more chronic and insidious. • Classical swine fever. Other body systems are also involved. • Atrophic rhinitis. Characteristic bony changes are seen in the turbinate bones. • Inclusion body rhinitis can look very similar in young pigs, but detection of inclusion bodies in this disease should confi rm its presence.
Diagnosis
Diagnosis is by ELISA on serum. PCR is used for virus detection from nasal swabs.
Post-mortem -Severe congestion of the upper respiratory tract is seen. Bronchial or mediastinal lymph nodes are enlarged and hyperaemic. The cervical and mediastinal lymph nodes are also enlarged. Thick exudate may be found in the bronchi. Localized redpurple areas of lung collapse in apical and cardiac lobes, the right lung worse than the left. Emphysema may surround collapsed areas. A necrotizing bronchiolitis may be present.
Inclusion body rhinitis
Incidence
The disease has worldwide incidence; >90% of UK herds are affected.
Aetiology
The cause is porcine cytomegalovirus (a herpesvirus).
Epidemiology
Transmission is by direct pig-pig contact or aerosol. Virus may be present in the urine. Inclusion body rhinitis mostly affects young pigs but one may get severe herd-wide infection in naive (e.g. minimum disease) herds. The virus can cross the placenta and thus could appear in hysterectomyderived herds. The virus may predispose to secondary infection with B. bronchiseptica and other respiratory pathogens.
Clinical signs
These are mostly in pigs <3 weeks of age. Sneezing may follow play fi ghting. There may be serous nasal discharge (occasionally bloody) and brown ocular discharge. High morbidity and low mortality occur, especially in chronically affected herds. In naive herds, signs may be much more severe. Piglets may have diarrhoea followed by anaemia, rhinitis, oedema, and death. Adult pigs may show respiratory signs. Stillbirth and abortion may occur in sows.
Treatment
Antibiotic therapy may help control secondary infection.
Differential diagnosis
• Atrophic rhinitis. Check herd history. Bony changes occur. • Necrotic rhinitis. Necrotic tissues and facial swelling are present. • Swine infl uenza has sudden onset and affects older pigs too. • Bordetella rhinitis is seen occasionally.
Diagnosis
Diagnosis is by ELISA test for serum antibodies and by the fi nding of inclusion bodies from nasal swabs and tissues including nasal infl ammation and discharge from killed piglets ( Fig. 4.12) .
Control
In a herd outbreak, it is benefi cial to protect suckling piglets from exposure to infection. Maintain a closed herd.
Segregate and rear young pigs off site. Success has been achieved in the USA with testing (ELISA and PCR) and culling from herds.
Vaccination -A freeze-dried vaccine with an adjuvanting diluent is available for use in pigs 6-9 weeks of age in an infected herd. After a single dose of vaccine, protection against the virus should be present for 14 weeks. For a fuller discussion on the control of this disease, please see Chapter 11 (Polysystemic diseases).
Treatment
Antibiotic therapy and good management may help overcome secondary respiratory infection.
Differential diagnosis
Differential diagnoses are other causes of respiratory disease, including enzootic pneumonia, H. parasuis, A. pleuropneumoniae, and P. multocida.
Diagnosis
Diagnosis is based on history.
Post-mortem -Interstitial pneumonia is found. Serology involves ELISA and PCR tests.
Porcine reproductive and respiratory syndrome
For a full discussion of this disease, please see Chapter 11 (Polysystemic diseases). Only respiratory aspects will be discussed here. The disease is also known as blue-eared pig disease and 'purrs'.
Incidence
The disease occurs in most pig-keeping areas of the world.
Aetiology
The cause is a virus (the PRRS virus) from the Arteriviridae family. There are US and European strains.
Epidemiology
The disease was fi rst identifi ed in the UK in 1991 and is now endemic in many herds. Respiratory disease may persist in an infected herd for years. A wide range of clinical signs have been associated with this disease. Infection may enter a herd with a carrier pig and spread by pig to pig contact. Flies may carry and spread the virus. Aerosol PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME transmission is less likely than is the case with enzootic pneumonia. PRRS virus can be a primary or secondary pathogen.
Clinical signs
Respiratory disease, pyrexia, anorexia, cough, dyspnoea, skin discoloration, and ill thrift are present (Fig. 11.13 ). About 25% of affected young pigs may die through secondary infection with Mycoplasma hyopneumoniae, H. parasuis, and other respiratory pathogens. There is lower mortality in older pigs. Respiratory signs may precede abortion in gilts. As disease becomes more endemic, respiratory signs and poor growth can be seen in weaners for several months.
Porcine respiratory coronavirus
Incidence
Evidence of this infection has been found in many parts of the world.
Aetiology
A coronavirus very similar to the transmissible gastroenteritis virus but distinguishable only by monoclonal antibody tests is the cause. Other serological tests do not distinguish the two conditions and may complicate testing for transmissible gastroenteritis.
Clinical signs
Experimentally, the virus has produced signs of bronchopneumonia, pyrexia, coughing, anorexia, and delayed growth. No gastrointestinal signs have been seen. The exact role of the virus in the fi eld is not known, but it may predispose to other respiratory diseases.
Aetiology
The causal organisms are Metastrongylus apri and Metastrongylus edentatus.
Epidemiology
The organism's life cycle requires the earthworm as the intermediate host, and hence the parasite occurs only where pigs have access to earth in an outside environment. Worms are found in the lungs 20-24 days after the pig consumes the thick-walled egg containing the lungworm fi rst-stage larva. The disease mostly affects young pigsadults appear to be immune.
Clinical signs
Coughing and dyspnoea occur in piglets or growing pigs. 
Diagnosis
The condition is diagnosed by virus isolation and monoclonal antibody serology.
Post-mortem -Catarrhal bronchopneumonia is present.
Control
An antibody-free herd may be maintained. However, a good level of antibodies will help protect the herd against transmissible gastroenteritis.
Diagnosis
Diagnosis is based on clinical signs, history, and management. It is confi rmed by fi nding thick-walled eggs containing a larva in the faeces.
Post-mortem -Adult worms 45 mm long are found in or can be squeezed out of the bronchi or bronchioles of the diaphragmatic lobes of the lungs. Areas of pulmonary emphysema may be seen in caudal parts of the diaphragmatic lung lobes (Fig. 4.13) .
Treatment
Anthelminthic therapy is used, for example ivermectin, doramectin, fenbendazole or fl ubendazole.
Control
Avoid access to the intermediate host if practical. Routine dosing of piglets is used.
Postweaning multisystemic wasting syndrome
Respiratory distress is seen in some affected pigs, caused chiefl y by pulmonary oedema. For a full discussion on postweaning multisystemic wasting syndrome, please see Chapter 11 (Polysystemic diseases).
Metastrongylosis
Incidence
Metastrongylosis is relatively uncommon, but the return to outdoor methods of pig keeping may increase the incidence.
